MedPath
NMPA Approval

Milnacipran Hydrochloride Tablets

国药准字H20234510

March 6, 2024

Drug Information

盐酸米那普仑片

片剂

25mg

化学药品

March 6, 2024

Company Information

Applicant Company

四川省泸州国家高新区医药产业园

Manufacturing Company

四川省泸州国家高新区医药产业园酒香大道8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸米那普仑片 - NMPA 批准文号 | MedPath